Down syndrome preleukemia and leukemia.

Down syndrome preleukemia and leukemia.

Children with Down syndrome (DS) and acute leukemias acute have unique biological, cytogenetic, and intrinsic factors that affect their treatment and outcome. Myeloid leukemia of Down syndrome (ML-DS) is associated with high event-free survival (EFS) rates and frequently preceded by a preleukemia co...

Full description

Bibliographic Details
Main Authors:	Maloney, K, Taub, J, Ravindranath, Y, Roberts, I, Vyas, P
Format:	Journal article
Language:	English
Published:	Elsevier 2014

Similar Items

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
by: Labuhn, M, et al.
Published: (2019)

Myeloid pre-leukemia and leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

Acute leukemias in children with Down syndrome.
by: Zwaan, C, et al.
Published: (2010)

Acute leukemias in children with Down syndrome.
by: Zwaan, M, et al.
Published: (2008)

Molecular insights into Down syndrome-associated leukemia.
by: Vyas, P, et al.
Published: (2007)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
by: Labuhn, M, et al.
Published: (2018)

Haematology of Down syndrome.
by: Webb, D, et al.
Published: (2007)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
by: Vyas, P, et al.
Published: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
by: Maroz, A, et al.
Published: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
by: Maroz, A, et al.
Published: (2014)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia
by: Winer, P, et al.
Published: (2020)

Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome
by: Li, S, et al.
Published: (2022)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
by: Norton, A, et al.
Published: (2007)

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
by: Vyas, P, et al.
Published: (2007)

Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
by: Roy, A, et al.
Published: (2012)

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
by: Bhatnagar, N, et al.
Published: (2016)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
by: Hellebostad, M, et al.
Published: (2005)

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
by: Gurbuxani, S, et al.
Published: (2004)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
by: Roberts, I, et al.
Published: (2013)

Haematopoietic development and leukaemia in Down syndrome
by: Roberts, I, et al.
Published: (2014)

Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia.
by: McDonell, N, et al.
Published: (2000)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.
by: Buitenkamp, T, et al.
Published: (2013)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
by: Buitenkamp, T, et al.
Published: (2013)

Sowing the seeds of leukemia before birth
by: Roberts, I, et al.
Published: (2021)

Transient abnormal myelopoiesis without constitutional Down syndrome
by: Kairiene, I, et al.
Published: (2019)

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
by: Tunstall, O, et al.
Published: (2018)

Natural history of GATA-1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2003)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
by: Garnett, C, et al.
Published: (2019)

Natural history of GATA1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2004)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
by: Roy, A, et al.
Published: (2009)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
by: Buitenkamp, T, et al.
Published: (2012)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
by: Buitenkamp, T, et al.
Published: (2012)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
by: Hasle, H, et al.
Published: (2008)